Jul 17, 2024 | Blog, Events
“Diversity in clinical trials” is undoubtedly one of the hottest topics in the healthcare industry today and with good reason. Underrepresentation in clinical trials can have significant and wide-ranging consequences — impacting the quality and applicability of...
Jul 9, 2024 | Blog, Events, Published Research
Chronic Lymphocytic Leukemia (CLL), a type of slow-growing cancer of the blood and bone marrow, accounts for 25-30 percent of all leukemia in the Western world and is the most common type of leukemia in adults, with over 100,000 new global incidence cases and over...
Jan 6, 2023 | Blog, Events, Published Research
In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...
Jun 25, 2021 | Blog, Events
This is the second in a series of posts on the lessons learned from key presentations at the recent ISPOR 2021, specifically as they relate to real-world data (RWD) and real-world evidence (RWE). Our first post focused on the increasing acceptance of RWD and RWE in...
Jun 14, 2021 | Blog, Events
This is the first in a series of three posts on the lessons learned from key presentations at the recent ISPOR 2021, specifically as they relate to real-world data and real-world evidence. In December of 2018, the FDA released its Framework for the Real-World Evidence...
Oct 31, 2019 | Events, Press Releases
Cambridge, MA, October 31, 2019 — TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that it will present nine new research findings at the...
